| Species | Human |
| Product Type | Tissue-derived Organoid |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Lung |
| Disease | Fibrosis(IPF), Infection Respiratory and ENT Disease |
| Generation Process | Tissue-derived lung organoids are established directly from tissue or biopsy samples. Cultured under optimized conditions that preserve the native genetic profile and cellular interactions, these organoids faithfully recapitulate the cellular composition and microenvironment of the original lung tissue. Their specific characteristics render them particularly valuable for personalized medicine, disease modeling, and translational research applications. |
| Organoid Characterization | Lung organoids accurately recapitulate the architecture of human lung tissue, including critical structures such as alveoli. They comprise a diverse range of cell types, including type I and II alveolar epithelial cells, ciliated cells, and secretory cells, effectively capturing the cellular complexity and functional properties of native lung tissue in a reproducible format. |
| Applications | Produced using optimized differentiation protocols, these organoids ensure consistent cellular composition and maturity, enabling reliable data generation from early discovery through translational applications. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.